Kegonsa Seed Fund


Founders: Steven J. Gordon, Jingyue Ju
Inventor: Jingyue Ju
Manager: Steven J. Gordon (CEO)
Industry: Bioinformatics, Biomedical Equipment and Manufacturing
Established: 2003
Headquarters: Waltham, Massachusetts

IBSI is developing a next-generation DNA sequencing system that increases the speed and reduces the cost of producing sequence data.

By making it easier and less expensive to sequence DNA, IBS's technology has the potential to dramatically change the way research is performed and health care is delivered.

Investment History:
  • Seed funding was provided by Steven J. Gordon and Jingyue Ju, the company founders, and angel investors.
  • The Kegonsa Seed Fund and current management invested in the Series A and Series B financing round.
  • In May 2012 IBSI was sold to a large Life Sciences tools and reagent-manufacturing company in an all-cash transaction.

Company Leaders

Steven J. Gordon, Ph.D. is the co-founder and CEO of IBSI

Before co-founding IBSI, Steven founded and self-funded Intelligent Automation Systems, a provider of technology and products for the semiconductor, photonics, and life sciences industries. Steven led Intelligent Automation Systems from its inception in 1987 through its sale to Brooks Automation in 2002.

Steven has a Ph.D. in mechanical engineering from MIT.

Jingyue Ju, Ph.D. invented the technology behind IBSI and co-founded the company.

Jingyue is the inventor on 19 patents—including two previous commercial successes—and author of 60 peer reviewed publications.

Jingyue has a Ph.D. in bio-organic chemistry from the University of Southern California.